Siemens Healthineers presented a new set of angiography platforms at the European Congress of Radiology (ECR) 2026 designed to support embolization procedures, including treatments for liver cancer. The systems incorporate artificial intelligence to assist with image quality, treatment planning and workflow guidance in interventional radiology.

The Erlangen, Germany-based company introduced three platforms in its updated Artis portfolio: Artis genio, Artis icono.explore and Artis icono.vision. The systems combine cone-beam CT imaging with AI-based software intended to support catheter navigation and procedural planning during embolization procedures.

One of the new tools, Syngo DynaCT MORE, focuses on motion correction in three-dimensional cone-beam CT data sets. Motion from breathing, heartbeat or pulsating vessels can degrade image quality in thoracic and abdominal scans, sometimes rendering data sets unusable. The software applies iterative reconstruction techniques to realign high-contrast structures such as vessels and devices, with the aim of restoring anatomical detail and reducing the need for repeat scans.
Siemens Healthineers also introduced myEmbolization Guide, an AI-based planning application that automates several manual steps in embolization procedures. The software provides organ-specific workflows, including for liver and prostate interventions. In liver embolization, the tool enables three-dimensional tumor contouring and mapping of surrounding vessels to help distinguish tumor-feeding vessels from non-feeders. The company said the mapping capability can assist with procedural planning and navigation.

The systems also incorporate the Optiq AI imaging chain, which uses an algorithm to reduce noise during image processing. According to Siemens Healthineers, the technology aims to improve image quality across several two-dimensional imaging modes without increasing radiation dose.

The updated platforms are intended to address growing demand for interventional procedures as patient volumes rise while staffing remains constrained. Embolization is commonly used to block blood flow to tumors or deliver localized therapy through targeted vessels, offering a minimally invasive alternative to some systemic treatments.

“Interventional radiology demands precision, and our new Artis portfolio represents a leap toward truly personalized therapy for cancer patients,” said Carsten Bertram, head of Advanced Therapies at Siemens Healthineers.

Prof. Dr. med. Frank K. Wacker, president of the German society for interventional radiology and minimally invasive therapy (DeGIR), said workflow guidance tools can help support training and reduce errors in complex procedures.

CT Homepage